Development and validation of a deep learning-based model to predict response and survival of T790M mutant non-small cell lung cancer patients in early clinical phase trials using electronic medical record and pharmacokinetic data.

When patients were divided into high and low groups according to the mean value of Css min and Ccr, patients with low Css min had longer PFS with marginally significant P value ( Figure 6D ) and the low Ccr group also had better survival significantly ( Figure 6D ).

also in 26,082 other papers